FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149132322> ?p ?o ?g. }

• W2149132322 endingPage "43" @default.
• W2149132322 startingPage "33" @default.
• W2149132322 abstract "Background The relative diagnostic accuracy of interferon γ release assays (IGRAs; based on ELISA [enzyme-linked immunosorbent assay] or ELISPOT [enzyme-linked immunosorbent spot], ie, the QuantiFERON and T-SPOT.TB tests, respectively) and the tuberculin skin test (TST) for latent tuberculosis (TB) infection in people with end-stage kidney disease is uncertain and national guidelines for their use are inconsistent. Study Design Systematic review. Selection Criteria for Studies Evaluated performance of tests for latent TB with clinical risk-factor assessment. Setting & Population People with end-stage kidney disease (chronic kidney disease stage 5 [eGFR <15] or kidney transplant recipients). No limits on setting. Index Tests ELISA- or ELISPOT-based IGRAs, TST, assays to detect antimycobacterial antibodies, and flow cytometry–based tests. Outcomes Odds of test positivity with clinical risk factor for latent TB, expressed as ORs and relative ORs (RORs). Results 47 studies (6,828 participants) were included, but only 30 studies (4,546 participants) contained sufficient data to contribute to meta-analysis. Studies were predominately in the dialysis population (23/30; 3,700 participants) in countries with low to moderate TB prevalence (0.0-50.0 cases/105 persons). BCG vaccination rate was variable (2.7%-100.0%). 9 studies compared IGRAs with the TST directly, 17 studies evaluated the TST only, and the other 4 studies evaluated other tests. Compared to a positive TST result, a positive ELISA-based IGRA result was associated more strongly with radiologic evidence of past TB (ROR, 4.29; 95% CI, 1.83-10.3; P = 0.001) and contact with active TB (ROR, 3.36; 95% CI, 1.61-7.01; P = 0.001). Compared to a negative TST result, a negative ELISA-based IGRA result was associated more strongly with BCG vaccination (ROR, 0.30; 95% CI, 0.14-0.63; P = 0.002). There were insufficient data to compare performance of the ELISPOT-based IGRA with the TST or ELISA-based IGRA. Limitations 17 of 47 included studies (36.2%) did not contain sufficient data to contribute to meta-analysis. Conclusions Compared to the TST, the ELISA-based IGRA was associated more strongly with risk factors for latent TB in end-stage kidney disease. The relative diagnostic accuracy of interferon γ release assays (IGRAs; based on ELISA [enzyme-linked immunosorbent assay] or ELISPOT [enzyme-linked immunosorbent spot], ie, the QuantiFERON and T-SPOT.TB tests, respectively) and the tuberculin skin test (TST) for latent tuberculosis (TB) infection in people with end-stage kidney disease is uncertain and national guidelines for their use are inconsistent. Systematic review. Evaluated performance of tests for latent TB with clinical risk-factor assessment. People with end-stage kidney disease (chronic kidney disease stage 5 [eGFR <15] or kidney transplant recipients). No limits on setting. ELISA- or ELISPOT-based IGRAs, TST, assays to detect antimycobacterial antibodies, and flow cytometry–based tests. Odds of test positivity with clinical risk factor for latent TB, expressed as ORs and relative ORs (RORs). 47 studies (6,828 participants) were included, but only 30 studies (4,546 participants) contained sufficient data to contribute to meta-analysis. Studies were predominately in the dialysis population (23/30; 3,700 participants) in countries with low to moderate TB prevalence (0.0-50.0 cases/105 persons). BCG vaccination rate was variable (2.7%-100.0%). 9 studies compared IGRAs with the TST directly, 17 studies evaluated the TST only, and the other 4 studies evaluated other tests. Compared to a positive TST result, a positive ELISA-based IGRA result was associated more strongly with radiologic evidence of past TB (ROR, 4.29; 95% CI, 1.83-10.3; P = 0.001) and contact with active TB (ROR, 3.36; 95% CI, 1.61-7.01; P = 0.001). Compared to a negative TST result, a negative ELISA-based IGRA result was associated more strongly with BCG vaccination (ROR, 0.30; 95% CI, 0.14-0.63; P = 0.002). There were insufficient data to compare performance of the ELISPOT-based IGRA with the TST or ELISA-based IGRA. 17 of 47 included studies (36.2%) did not contain sufficient data to contribute to meta-analysis. Compared to the TST, the ELISA-based IGRA was associated more strongly with risk factors for latent TB in end-stage kidney disease." @default.
• W2149132322 created "2016-06-24" @default.
• W2149132322 creator A5010964622 @default.
• W2149132322 creator A5016575685 @default.
• W2149132322 creator A5034225905 @default.
• W2149132322 creator A5038938109 @default.
• W2149132322 creator A5039834479 @default.
• W2149132322 creator A5041130177 @default.
• W2149132322 creator A5057219976 @default.
• W2149132322 creator A5071786802 @default.
• W2149132322 date "2013-01-01" @default.
• W2149132322 modified "2023-10-18" @default.
• W2149132322 title "Tests for Latent Tuberculosis in People With ESRD: A Systematic Review" @default.
• W2149132322 cites W1615951294 @default.
• W2149132322 cites W1965108947 @default.
• W2149132322 cites W1966700574 @default.
• W2149132322 cites W1975506045 @default.
• W2149132322 cites W1979346875 @default.
• W2149132322 cites W1980330109 @default.
• W2149132322 cites W1981043548 @default.
• W2149132322 cites W1984004386 @default.
• W2149132322 cites W1985323674 @default.
• W2149132322 cites W1985860622 @default.
• W2149132322 cites W1986215525 @default.
• W2149132322 cites W1997996982 @default.
• W2149132322 cites W2004571205 @default.
• W2149132322 cites W2005266330 @default.
• W2149132322 cites W2008333878 @default.
• W2149132322 cites W2015487603 @default.
• W2149132322 cites W2016743683 @default.
• W2149132322 cites W2027411496 @default.
• W2149132322 cites W2030021013 @default.
• W2149132322 cites W2037009355 @default.
• W2149132322 cites W2037060049 @default.
• W2149132322 cites W2037631554 @default.
• W2149132322 cites W2040580526 @default.
• W2149132322 cites W2041554851 @default.
• W2149132322 cites W2062061711 @default.
• W2149132322 cites W2077709009 @default.
• W2149132322 cites W2080270312 @default.
• W2149132322 cites W2095692467 @default.
• W2149132322 cites W2095930311 @default.
• W2149132322 cites W2097200325 @default.
• W2149132322 cites W2098741005 @default.
• W2149132322 cites W2099785108 @default.
• W2149132322 cites W2105239955 @default.
• W2149132322 cites W2105368166 @default.
• W2149132322 cites W2110241349 @default.
• W2149132322 cites W2111728452 @default.
• W2149132322 cites W2118198521 @default.
• W2149132322 cites W2120813027 @default.
• W2149132322 cites W2121977452 @default.
• W2149132322 cites W2133167384 @default.
• W2149132322 cites W2147493587 @default.
• W2149132322 cites W2150178651 @default.
• W2149132322 cites W2150238212 @default.
• W2149132322 cites W2151547142 @default.
• W2149132322 cites W2152132961 @default.
• W2149132322 cites W2153807711 @default.
• W2149132322 cites W2154482 @default.
• W2149132322 cites W2170678314 @default.
• W2149132322 cites W2334248695 @default.
• W2149132322 cites W2343385138 @default.
• W2149132322 cites W2418210342 @default.
• W2149132322 cites W4242069392 @default.
• W2149132322 doi "https://doi.org/10.1053/j.ajkd.2012.07.019" @default.
• W2149132322 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23068425" @default.
• W2149132322 hasPublicationYear "2013" @default.
• W2149132322 type Work @default.
• W2149132322 sameAs 2149132322 @default.
• W2149132322 citedByCount "46" @default.
• W2149132322 countsByYear W21491323222013 @default.
• W2149132322 countsByYear W21491323222014 @default.
• W2149132322 countsByYear W21491323222015 @default.
• W2149132322 countsByYear W21491323222016 @default.
• W2149132322 countsByYear W21491323222017 @default.
• W2149132322 countsByYear W21491323222018 @default.
• W2149132322 countsByYear W21491323222019 @default.
• W2149132322 countsByYear W21491323222020 @default.
• W2149132322 countsByYear W21491323222021 @default.
• W2149132322 countsByYear W21491323222022 @default.
• W2149132322 countsByYear W21491323222023 @default.
• W2149132322 crossrefType "journal-article" @default.
• W2149132322 hasAuthorship W2149132322A5010964622 @default.
• W2149132322 hasAuthorship W2149132322A5016575685 @default.
• W2149132322 hasAuthorship W2149132322A5034225905 @default.
• W2149132322 hasAuthorship W2149132322A5038938109 @default.
• W2149132322 hasAuthorship W2149132322A5039834479 @default.
• W2149132322 hasAuthorship W2149132322A5041130177 @default.
• W2149132322 hasAuthorship W2149132322A5057219976 @default.
• W2149132322 hasAuthorship W2149132322A5071786802 @default.
• W2149132322 hasBestOaLocation W21491323222 @default.
• W2149132322 hasConcept C126322002 @default.
• W2149132322 hasConcept C142724271 @default.
• W2149132322 hasConcept C156957248 @default.
• W2149132322 hasConcept C203014093 @default.
• W2149132322 hasConcept C2776090121 @default.
• W2149132322 hasConcept C2776247216 @default.

• next